These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7159463)

  • 1. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
    Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
    Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis.
    Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM
    Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis.
    Mingeot-Leclercq MP; Piret J; Tulkens PM; Brasseur R
    Biochem Pharmacol; 1990 Aug; 40(3):499-506. PubMed ID: 2383283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies.
    Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM
    Antimicrob Agents Chemother; 1983 Mar; 23(3):440-9. PubMed ID: 6847172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases.
    Mingeot-Leclercq MP; Laurent G; Tulkens PM
    Biochem Pharmacol; 1988 Feb; 37(4):591-9. PubMed ID: 3342096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal phospholipase A1.
    Piret J; Kishore BK; Tulkens PM
    Biochem Pharmacol; 1992 Feb; 43(4):895-8. PubMed ID: 1540243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities.
    Brasseur R; Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM; Ruysschaert JM
    Biochem Pharmacol; 1985 Apr; 34(7):1035-47. PubMed ID: 3985990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers.
    Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM
    Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity.
    Van Bambeke F; Montenez JP; Piret J; Tulkens PM; Courtoy PJ; Mingeot-Leclercq MP
    Eur J Pharmacol; 1996 Oct; 314(1-2):203-14. PubMed ID: 8957238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
    Kacew S
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
    Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study.
    Carlier MB; Laurent G; Tulkens P
    Arch Toxicol Suppl; 1984; 7():282-5. PubMed ID: 6595993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
    Viotte G; Olier B; Morin JP; Godin M
    Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.
    Hostetler KY; Hall LB
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro.
    Hostetler KY; Hall LB
    Biochim Biophys Acta; 1982 Mar; 710(3):506-9. PubMed ID: 7074128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.